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Abstract Adult late-onset Pompe disease is most often a
slowly progressive limb-girdle and spine extensormuscle dys-
trophy, due to defective lysosomal acid maltase. With the ex-
ception of the few patients who present with a dramatically
accelerated clinical course, standard diagnostic imaging fail to
detect and evaluate disease progression between two succes-
sive visits. In muscle dystrophy of very rapid evolution, like
the Duchenne disease, quantitative NMR imaging has suc-
cessfully demonstrated its capacity to objectivate both disease
activity and degenerative changes progression over short
follow-up periods. The purpose of this retrospective
monocentric open-label study was to investigate whether
quantitative NMR imaging can monitor disease progression
in adult Pompe patients despite its very slow nature. Quanti-
tative imaging of Pompe patients succeeded in demonstrating
that muscle fatty infiltration increased on average by 0.9 %/
year, with the hamstring and adductor muscles showing the
fastest degradation. Muscle water T2 mapping revealed that
32 % of all muscles had abnormally high T2 in at least one of
two successive examinations. When muscle water T2 was
abnormal, fatty degenerative changes were further increased
by 0.61 %/year. Enzyme replacement therapy resulted in
0.68 %/year slowdown of the muscle fatty infiltration, in both
muscles with normal and high T2s.
Introduction
Nuclear magnetic resonance (NMR) imaging has an
established role in the diagnosis of inherited and metabolic
muscle diseases (Wattjes et al 2010). In recent years, medical
imaging has acquired a new dimension; it has become quan-
titative (Tofts 2003), the generation of parametric maps, in
which voxel signal intensity is not in arbitrary units anymore
but is the true reflection of a biological (% fat) or of an NMR
(water T2) variable. For muscle disorders as for other ail-
ments, the benefits of quantitative imaging are multiple: a
better appreciation of disease severity, the possibility to mon-
itor pathological changes over time and, most importantly, to
evaluate skeletal muscle responses to therapeutic intervention.
Quantitative variables and indices derived from NMR imag-
ing but also spectroscopy constitute the most serious imaging
candidates as biomarkers or outcome measures in clinical tri-
als focusing on muscle pathology (Hollingsworth et al 2012).
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The percentage of fat in muscle signal, commonly referred
to as the percentage of fat, and the muscle water T2, not to be
confused with the muscle global T2 (Carlier 2014), are cur-
rently the two NMR quantitative indices proposed to charac-
terize a diseased muscle with imaging (Hollingsworth et al
2012). They convey very different information.
There exists several technical possibilities to separate water
and fat signals in NMR images and, from these, to construct
parametric maps of the percentage of fat signal in the images
(Hu et al 2012). The percentage of fat in a chronically diseased
muscle informs on the extent of the structural changes, by
measuring the degree and extent of fatty involution of the
damaged muscles. Water-fat imaging, using the Dixon tech-
nique, was able tomeasure the progression of the degenerative
changes in thigh and lower leg muscles of limb-girdle muscu-
lar dystrophy (LGMD) 2I patients (Willis et al 2013). Adult
form of Pompe disease is, inmost patients, a disease of slow to
very slow progression. Whether quantitative NMR imaging
would be sensitive enough to pick up the small changes in
muscle composition had to be ascertained.
Skeletal muscle cell T2, as more generally tissue water T2,
is devoid of specificity and may be abnormal in a variety of
pathological conditions. It is nevertheless an excellent indica-
tor of the intensity of the underlying mechanisms and may be
taken as a non-specific but sensitive indicator of Bdisease
activity^ (Tardif-de Géry et al 2000; Walter et al 2005;
Thibaud et al 2007; Arpan et al 2013). Again it was valuable
to determine whether quantitative T2 mapping would be able
to evaluate disease activity in less aggressive forms of muscle
dystrophy, like adult Pompe patients.
The benefit obtained by enzyme replacement therapy has
been difficult to demonstrate unambiguously at least in
adult Pompe patients (Güngör et al 2013). A further chal-
lenge for quantitative NMR imaging is to provide direct
evidence of the effect of treatment on muscle structure and
to gain acceptance as an outcome measure (Lachmann and
Schoser 2013).
Muscle imaging, including quantitative sequences, has
been part of the routine yearly follow up of the Pompe patients
at the Institute of Myology, Paris for several years. Using this
database, we decided to address several questions:
– Can quantitative water-fat imaging of skeletal muscle as-
sess the progression of the fatty degenerative changes in
muscles of adult Pompe patients?
– What degree of disease activity and what percentages of
muscle involved does T2 mapping measure in the same
patients?
– Is there a link between disease activity, as measured by T2
maps, and progression of the fatty degenerative changes
in this population?
– Does enzyme replacement therapy have an effect on the
progression of muscle damages in adult Pompe patients?
Subjects/materials and methods
Patients
Twenty-three patients, six males and 17 females, aged 22
to 69 years (49.0±17.7 years), with a molecular diagnosis
of Pompe disease, were retrospectively studied. All were
followed at the Paris East Reference Center for Neuro-
muscular Disorders headed by Professor B. Eymard, In-
stitute of Myology, Pitie-Salpetriere University Hospital,
Paris. Population characteristics are given in a supplemen-
tal table.
Of the 23 patients, 14 were treated with enzyme replace-
ment therapy (alglucosidase alfa, Myozyme®, Genzyme-
Sanofi), for an average of 44±20 months. The decision by
the physicians in charge to treat was essentially taken ac-
cording to disease severity. As a consequence, disease bur-
den was more important on muscles of treated patients than
on those of untreated ones and this prevented direct com-
parison of quantitative measurements between the two sub-
groups.
Muscle imaging was part of the standard care provided to
the Pompe patients at the Institute of Myology. All clinical
data and complementary exams results were encoded in the
French Pompe register. The natural history protocol of the
untreated Pompe patients had received approval of the local
ethics committee, as did alglucosidase alfa continuation agree-
ment that most treated patients fell under.
For quantitative imaging, patients were examined in supine
position, feet first.
NMR equipment
Imaging was performed at 3 T on a Siemens Trio TIM ma-
chine, with elements of the spine receiver coils activated and
three flexible Bbody^ array coils covering anteriorly from an-
kles to hips.
NMR imaging protocol
All patients were scanned at least twice at 1-year interval, 13
patients were examined three times and two were scanned
during four consecutive years.
Standard T1w spin echo (SE) of the thigh and lower leg
was first performed and muscle fatty degenerative changes
were scored according to the Lamminen-Mercuri scale (grade
1: normal; grade 2: <30 %; grade 3: >30 % and <60 %; grade
4: >60 %).
Water-fat imaging of the entire lower limb was obtained
with a modified Dixon sequence because of the unavailability
of 3-point Dixon on Siemens machines. Two three-
dimensional gradient echo (GE) volumes were acquired per
segment, one with echo times (TE) of 2.75 and 3.95 ms, one
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with TEs of 2.75 and 5.15 ms, in order to collect the in-out-in
images of a standard 3-point Dixon approaches. Slab volume
was 448×448×320 mm, with a spatial resolution of
1×1×5 mm. The repetition time (TR) was 10 ms, with a flip
angle of 3°, to ensure a proton-density weighting, and to be as
close as possible to the hydrogen distribution in water and
lipids. Amplitude and phase images were stored for water
and fat image processing.
Quantitative T2 measurements were based on standard
multi-slice multi echo time (TE) spin echo (SE) se-
quences. Seventeen echoes with an inter-echo spacing of
9.5 ms were acquired with a 3000 ms repetition time and
an acceleration factor of 2. Two slabs of 11 slices, 10 mm
thick, with 15 mm slice gap, were centered at mid-thigh
and on the proximal third of the lower leg. In-plane reso-
lution was 1.4×1.4 mm. No fat saturation module was
activated.
Three-dimensional B1 mapping was collected with an op-
timized version of the actual flip angle imaging (AFI) se-
quence (Yarnykh 2007) provided by A. Amadon from
Neurospin, CEA, France. The slabs encompassed the volumes
scanned with the multiTE SE sequences.
Average scanning time was 90 min, in two sessions to
include whole-body T1 weighted imaging which was per-
formed head-first.
Altogether, 59 imaging sessions were reviewed, all but
eight comprised both thighs and lower legs.
Image analysis
Water, fat and percentage of fat volumes were recon-
structed as previously described (Glover and Schneider
1991; Ma 2008) (Fig. 1).
Percentage of fat images were extracted at the same spatial
coordinates as the multi-TE SE images and individual muscle
fatty infiltration was measured.
Muscle water T2 values were calculated using a tri-
exponential fitting procedure which allowed the separation
from the fatty infiltrative component (Azzabou et al 2014).
Threshold for abnormality was set at 2 standard deviation
above mean muscle water T2 of volunteers, 39 ms.
Statistics
Results are expressed as mean±standard deviation.
Main variables, fat fraction, annual progression of fat frac-
tion, and water T2 were analyzed using an analysis of variance
(ANOVA) with between (treatment, high T2 vs normal T2)
and within (muscle, segment, time) factors.
Linear relations between main variables were also
determined.
Results
Yearly progression of muscle fatty degenerative changes
in the lower limbs of Pompe patients
Lamminen-Mercuri visual grading of T1w images of the
thigh was 1.7±1.0. In the lower leg, scores were close to
normal (1.1±0.3). No change in grading was noted over a
1-year observation period (0.0±0.2). By contrast, the ap-
parent fat content as defined in the Methods increased on
average by 0.9±0.2 %/year (p<0.0001), all muscles of the
lower limb considered. Individual muscle analysis, as
displayed in Fig. 2, showed that intramuscular fatty de-
generation progressed more rapidly in the thigh than in
the lower leg, with the adductors longus and magnus
experiencing the faster rate of fatty infiltration. In the
lower leg, the gastrocnemius medialis was the only mus-
cle for which fat content increased noticeably between
exams. There was overall a very significant and logical
correlation between the yearly rate of fatty replacement
and the extent of the fatty degenerative changes. The mus-
cles that were the most altered would be expected to be
the ones in which the degenerative replacement process















Fig. 1 Examples of percentage of fat images generated from Dixon
acquisitions in the thigh (left) and in the lower leg (right). The upper
row was obtained at initial examination, the lower row show images at
1-year follow-up. The figures in white give the fat percentages in selected
muscle — from top and clockwise, quadriceps, adducor longus, semi-
membranous and biceps femoris, in the thigh; tibialis anterior,
gasctrocnemius medialis, soleus, gastrocnemius lateralis and extensor
digitorum, in the lower leg. In this example, the mean increase in fat
infiltration was 2.9 % in the thigh and 0.9 % in the lower leg
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Disease activity as estimated by elevatedwater T2 in the lower
limb of Pompe patients
Of the 1101 muscles that were analyzed, 241 had abnormally
high muscle water T2 (>39 ms) in at least one of two succes-
sive scans, and 113 had elevated T2 on both occasions. This
amounted to 32% of all investigated muscles displaying signs
of disease activity in at least one of two successive follow-up
examinations. Individual muscle analysis again revealed im-
portant differences across muscles (Fig. 3). Muscles that were
systematically found with abnormal water T2 were all located
in the thigh: the biceps femoris, the semi-membranous and the
adductor magnus.
Link between disease activity as revealed by high T2
and muscle degenerative progression as measured by the fatty
infiltration rate
When muscle water T2 was abnormal, the progression rate of
fatty infiltration was 0.61 %/year higher than when T2 was
found within the normal range (p=0.02). Muscles having a
higher T2 were muscles experiencing on average the faster
progression of the fatty degenerative changes (Fig. 3c).
Effect of enzyme replacement therapy on the progression
of the lower limb degenerative changes
In muscles of patients who were benefiting from enzyme re-
placement therapy with alglucosidase alfa, the yearly progres-
sion rate of fatty infiltration rate was lower by 0.68 %/year as
compared to the untreated patients (p=0.01). In muscles with
normal water T2, muscle degenerative changes were
completely stopped (Fig. 4).
Discussion
This work demonstrates that quantitative NMR (qNMR) im-
aging techniques are able to monitor disease progression in
skeletal muscles of patients with low-activity dystrophic le-
sions, as here in late-onset Pompe disease.
Visual scoring versus quantitative analysis of muscle imaging
data
Routine diagnostic T1w MRI of muscle disorders makes uses
of visual grades, typically from 0 or 1 for normal to 4 for full
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Fig. 2 In A, the mean yearly increase in fat percentage is given muscle
by muscle in the lower leg (on the left) and in the thigh (on the right).
Using the same display, the degree of fatty degeneration is shown in B.
There was a strong linear relationship between the extent of the fatty
infiltrations and their progression as estimated by the annual increase in
muscle fat content (see C)
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replacement by fat, to characterize the extent of the degener-
ative changes on a per muscle basis (Lamminen 1990). This is
largely sufficient to characterize the patterns that will poten-
tially orient toward a particular causative gene. However,
common sense tells us that, with these so called Bsemi
quantitative^ scales, progression from one class to the next
requires on average 12.5 or 16.5 % increase in muscle fat
content. This is a most unlikely event over a 1- or 2-year
follow-up, even in the most severe of muscle dystrophies.
Here, in a much milder form of dystrophy, it was virtually
% FAT INCREASE PER YEAR
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Fig. 3 A high percentage of muscles, 32 %, were found with an
abnormally high T2 in at least one of two successive imaging sessions
as displayed by the pie-chart in A. Mean T2s for individual muscles are
given in B, with the horizontal line at 39 ms representing the abnormality
threshold. The adductor magnus, semi-membranous and biceps femoris
had the highest disease activity. Mean muscle T2 was correlated with the


















Fig. 4 Effect on enzyme replacement therapy on the progression of the
fatty degenerative changes. Treatment was effective both in muscle with
normal T2 (left panel) and with elevated T2 (right panel). In muscles
with normal T2s, the progression of the degenerative changes was
completely blocked
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foretold that the Lamminen-Mercuri scales would not be able
to detect muscle degenerative changes, just as they previously
failed to identify progression in an LGMD2I patient longitu-
dinal study (Willis et al 2013).
The T2w STIR sequences so popular among clinicians and
radiologists do not suffer from any similar sensitivity issue,
but the problem lies in the qualitative nature itself of the in-
formation generated by such sequences. One looks visually
for contrast between abnormal and normal muscles or areas. If
all muscles in a segment are inflamed, the exam is likely to be
considered falsely negative. Such situation was encountered
in juvenile dermatomyositis patients (Carlier et al 2013).
However, in a population like the Pompe patients, the major
shortcoming of STIR sequences is the inability to objectively
compare different patients or successive exams of the same
patients in a longitudinal study.
Awareness of these limitations made us turn to carefully
selected qNMR sequences for the longitudinal characteriza-
tion of skeletal muscle involvement in this Pompe patient
population. The low values of the progression of alterations
which were detected between routine yearly follow-up justi-
fied this decision a posteriori but also demonstrated the power
of qNMR approaches as compared to routine MRI when, be-
yond purely diagnostic questions, it comes to disease
characterization.
Monitoring of muscle degenerative changes with quantitative
muscle imaging
Quantitative water-fat imaging using a Dixon sequence was
able to detect skeletal muscle fatty degenerative changes pro-
gression, which was overall very small, less than 1 %/year in
our population. This demonstrates the excellent sensitivity of
the technique and confirms results recently published in a
multi-center trial aiming at monitoring the structural changes
in lower limb muscles of LGMD patients of type 2I (Willis
et al 2013). The fat deposition rate, which was already slow in
that population with an average of approximately 2 %/year,
was even lower here in adult Pompe patient but was unambig-
uously captured. This confers quantitative Dixon sequences a
unique value as a biomarker of the skeletal muscle structural
changes in NMD patients.
Similarly to the LGMD2I study, important inter-muscle
differences were noted, here with the fastest degradation re-
corded in the hamstring and in the thigh adductors. The sig-
nificance and validity of these individual differences was con-
firmed by the strong correlation between the fatty infiltration
progression rate and the severity of muscle involvement, the
muscles with the fastest degenerative changes being the ones
with the highest fat content. Since all muscles were initially
fat-free, this had logically to be the case at least until sub-total
fat replacement occurred.
Such benchmarking was important because it might in-
crease the discriminative power of muscle imaging outcome
measures by a selection of the most appropriate targets.
Dixon sequence parameters were selected to generate the
highest proton-density weighing while maintaining an accept-
able signal-to-noise ratio and therefore to provide fat percent-
age parametric maps that were as close as possible to the real
hydrogen atom distribution between water and lipids.
Fibrosis is the other main chronic structural change that
may develop in skeletal muscles of NMD patients. Attempts
to evaluate interstitial fibrosis with standard NMR or Dixon
imaging sequences have so far been inconclusive. Optimized
B1 transmitter and receiver field compensation might in the
future be able to reveal the drop in NMR signal intensity that
ought to be associated with the presence of fibrotic tissue. This
was not implemented in this study and therefore no informa-
tion on abnormal connective tissue deposition was obtained.
So far, the most promising sequence to quantify fibrosis are
the ultra-short TE (UTE) sequences, that are not yet routinely
used.
Evaluation of Bdisease activity^ with quantitative muscle
imaging
Contrary to global T2 (Carlier 2014), muscle water T2 of fatty
infiltrated muscle is a non-specific but sensitive index of what
may be called Bdisease activity^ (Carlier et al 2013). Despite
the slowly progressive nature of late onset Pompe disease, the
percentage of muscle displaying abnormally high T2 values
was surprisingly almost one third in our population sample.
The observation was all the more unexpected, that significant
inflammatory reaction is most often absent at histological ex-
amination of Pompe biopsies. It can then be hypothesized that
abnormal T2 could then rather reflect myocytic lesions, pos-
sibly in relation with lysosomal rupture. A link between high
T2 and glycogen accumulation has sometimes been sug-
gested. This seems unlikely. The T2 deconvolution experi-
ments by Saab et al have, on the contrary suggested that water
in close interaction with glycogen had shorter T2s than free
water (Saab et al 2000). Also, McArdle patients who system-
atically have much higher glycogen content (Jehenson et al
1991) than Pompe patients show only a slight increase in
muscle T2s (de Kerviler et al 1991). These evidence make a
direct role of glycogen in the water T2 changes very improb-
able. It must also be recognized and stressed that the muscle
T2 elevation noted in Pompe was of much lower amplitude
than it can be in inflammatory myopathies, which is potential-
ly compatible with the minimal degree of inflammation in
Pompe and a more direct role of subtle myocyte lesions per se.
Muscles with abnormal T2s belong to the thigh, andmainly
to the posterior segment, which are also the muscles of the
lower limb in which the degenerative changes are classically
most prevalent. Since a bias introduced by fat T2 can be ruled
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out with the processing method we use, this observation sup-
ports the contention that abnormal T2 might reveal disease
aggressiveness. Additional evidence of this is discussed in
the next paragraph.
Link between disease activity and progression of degenerative
changes
In patients suffering from fascio-scapulo humeral dystrophy
(FSHD), it was shown that muscles with hyperintensities on
T2w images would subsequently display significant fatty de-
generative changes on later follow up scans (Friedman et al
2013). The future usefulness of T2 as a NMR biomarker in
neuro-muscular therapeutic trials will depend on the solidity
of the evidence in favor of such a predictive role.
Muscle of Pompe patients with abnormal water T2 experi-
enced a faster progression of the degenerative changes. The
absolute increment was small, but it could not have been oth-
erwise with such an intrinsically slow progression of the dis-
ease. In relative terms however, an elevated water T2 implied
almost a doubling of the fatty infiltration rate. Such an obser-
vation is pivotal in establishing the utility of muscle water T2
as a biomarker of disease activity in NMDs.
Also, anatomical segregation of muscles revealed a loose
but significant correlation between mean muscle T2 and mean
rate of progression of fatty infiltration, further supporting the
predictive value of water T2. Fluctuations of T2 during the
course of the disease might have impacted on the correlation,
T2 being more an instant picture of the disease activity while
fat percentage mapping provides more of an integrator of
global disease burden over time. This explains why the two
NMR variables are both of importance and complementary to
assess consequences of the disease on muscles.
Effect of treatment
In this open label retrospective study, the decision to initiate
treatment had been taken by the physicians in charge accord-
ing to the patient’s clinical presentation. As a result, the extent
of the degenerative changes was significantly more severe in
the patients receiving the enzyme replacement therapy
(Lamminen-Mercuri 2.4±0.2 in treated patients vs 1.5±0.3
in untreated patients, p<0.01). Still it was possible to compare
the progression of the structural changes in muscles of treated
versus untreated patients. We assumed that response to treat-
ment would be independent of the initial degree of muscle
involvement, which is not guaranteed. Nonetheless, if such
bias existed here, if anything, it would likely have made the
demonstration of a-glucosidase effect more problematic be-
cause of the more advanced lesions in the treated group.
Data gathered over the last decade now unambiguously
show that enzyme replacement therapy improve life expectan-
cy of late onset Pompe patients (Güngör et al 2013). Evidence
of functional improvement was far less spectacular with a mod-
est increase in the 6MWT distance and no change in pulmonary
FVC (Lachmann and Schoser 2013). Effect of treatment on
muscle structure has even been more difficult to prove, despite
apparent clearance of glycogen (Thurberg et al 2006). An in-
crease in muscle trophicity of 3 to 8 % over 6-month of treat-
ment was nicely identified by a quantitative analysis of MRI
data. It was surprisingly associated with a comparable accumu-
lation of subcutaneous fat (Ravaglia et al 2010).
In the present report, enzyme replacement therapy resulted
in a lesser percentage of intramuscular fat. The effect is mod-
est but highly significant and the overall yearly accumulation
of intramuscular fat was small anyhow. A bit surprisingly, the
decrease in percentage fat signal was identical in muscles with
normal and high T2s and treatment was not associated with a
decrease in muscle T2. The mechanisms responsible for the
decrease in fat fraction accumulation rate under enzyme re-
placement therapy are to be further elucidated. Whether it
might or not, partly or totally, reflect indirectly an increase
in muscle mass is a possibility that has to be explored.
NMR vs other outcome measures
The comparison of the qNMR data with the other and mainly
the functional outcome measures was beyond the scope of this
report and has yet to be performed. Studies have unambigu-
ously demonstrated the superiority of qNMR over routine
functional assessment to document disease progression in oth-
er diseases. It was the case in a longitudinal multicentric nat-
ural history study of LGMD2I adult patients (Willis et al
2013). It was similarly shown in the large pediatric survey of
young Duchennemuscular dystrophy patients in the US (Will-
cocks et al 2014).
Conclusion
This retrospective monocentric study demonstrated the value
of qNMR imaging in the context of a longitudinal monitoring
of muscle lesions in adult Pompe patients and provided un-
ambiguous answers to our questions:
– quantitative water-fat imaging of skeletal muscle can as-
sess the slow progression of the fatty degenerative chang-
es in muscles of adult Pompe patients;
– up to one-third muscles of the lower limbs showmoderate
signs of disease activity revealed by high water T2 in
these patients;
– disease activity, as measured by T2 maps, is a predictor of
progression of the fatty degenerative changes in this
population;
– enzyme replacement therapy can limit the progression of
muscle damages in adult Pompe patients.
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